Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoling Peng

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Sensors (Basel, Switzerland)|August 12, 2023
Spatially Modulated Fiber Speckle for High-Sensitivity Refractive Index SensingPenglai Guo, Huanhuan Liu, Zhitai Zhou, et al.
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in ChinaPingjin Gao, Kezhi Mei, Hongwei Li, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophyShanshan Yao, Xin Yang, Meishen Ren, et al.
Plos Biology|July 19, 2024
Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitisHeejin Jun, Shanshan Liu, Alexander J Knights, et al.
Nature Communications|January 13, 2015
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesisShannon M Reilly, Maryam Ahmadian, Brian F Zamarron, et al.
Nature Metabolism|July 23, 2020
Catecholamines suppress fatty acid re-esterification and increase oxidation in white adipocytes via STAT3Shannon M Reilly, Chao-Wei Hung, Maryam Ahmadian, et al.
European Journal of Anaesthesiology|January 29, 2026
Prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trialTiantian Chu, Xiaoling Peng, Keliang Wan, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Sensors (Basel, Switzerland)|August 12, 2023
Spatially Modulated Fiber Speckle for High-Sensitivity Refractive Index SensingPenglai Guo, Huanhuan Liu, Zhitai Zhou, et al.
Current Therapeutic Research, Clinical and Experimental|August 8, 2019
Clinical Efficacy and Safety of Combination Therapy with Amlodipine and Olmesartan or an Olmesartan/Hydrochlorothiazide Compound for Hypertension: A Prospective, Open-Label, and Multicenter Clinical Trial in ChinaPingjin Gao, Kezhi Mei, Hongwei Li, et al.
Acta Pharmaceutica Sinica. B|July 15, 2026
AI-powered therapeutic aptamer drug discovery: Targeting the CT-domain of CTGF for duchenne muscular dystrophyShanshan Yao, Xin Yang, Meishen Ren, et al.
Plos Biology|July 19, 2024
Signaling through the nicotinic acetylcholine receptor in the liver protects against the development of metabolic dysfunction-associated steatohepatitisHeejin Jun, Shanshan Liu, Alexander J Knights, et al.
Nature Communications|January 13, 2015
A subcutaneous adipose tissue-liver signalling axis controls hepatic gluconeogenesisShannon M Reilly, Maryam Ahmadian, Brian F Zamarron, et al.
Nature Metabolism|July 23, 2020
Catecholamines suppress fatty acid re-esterification and increase oxidation in white adipocytes via STAT3Shannon M Reilly, Chao-Wei Hung, Maryam Ahmadian, et al.
European Journal of Anaesthesiology|January 29, 2026
Prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trialTiantian Chu, Xiaoling Peng, Keliang Wan, et al.
Pageof 9